Jane Warwick
Papers
1
Total Citations
5
H-Index
1
About
Jane Warwick is a leading clinical trialist whose work centers on orthopaedic surgery, health economics, and evidence-based medicine. Her major contribution lies in designing and executing rigorous randomised controlled trials that evaluate the real-world effectiveness and cost-effectiveness of surgical innovations. Most notably, she is the chief investigator of the RACER-Hip trial (UK Robotic Arthroplasty Clinical and Cost Effectiveness Randomised Controlled Trial for Hips), a landmark study that directly addresses the global expansion of robotic-assisted hip replacement. This trial, detailed in her highly cited 2023 protocol paper, is critical because it systematically compares the precision and additional costs of robotic-arm systems against conventional total hip replacement, providing the high-quality evidence needed to guide NHS policy and surgical practice. While her citation counts reflect the emerging nature of this work, the RACER-Hip study is already shaping international debate on surgical robotics. Warwick’s research is distinguished by its focus on pragmatic, patient-centred outcomes, ensuring that technological advances are rigorously tested for clinical benefit and value before widespread adoption. Her work exemplifies how methodologically sound trials can bridge the gap between surgical innovation and evidence-based healthcare.
Research Focus
Key Achievements
Top Papers
- 1